Biden Administration Facing Growing Calls To Share Vaccines Globally

The transcript discusses the potential use of surplus COVID-19 vaccines by the US as a diplomatic tool. It highlights the US's agreement to share vaccines with Canada and Mexico, emphasizing that these agreements are not based on quid pro quo. The transcript also compares the US's efforts with those of Russia and China, who have been more proactive in distributing vaccines globally. The Biden administration aims to contribute to the global pandemic solution but is cautious about making premature decisions due to unpredictable virus variants. The US has a significant stockpile of AstraZeneca vaccines, which are likely candidates for international distribution.

What is one reason experts believe the US should increase its vaccine diplomacy?

• To limit vaccine production

• To reduce the cost of vaccines

• To improve foreign policy objectives

• To increase domestic vaccine supply

What did Mexican officials say about the vaccine agreement with the US?

• It was a temporary arrangement

• It was not a quid pro quo deal

• It was made with strings attached

• It was a quid pro quo deal

How have Russia and China differed from the US in their vaccine distribution efforts?

• They have not distributed any vaccines

• They have focused only on domestic distribution

• They have been more generous

• They have been less generous

What is a major challenge the US faces in deciding how to distribute excess vaccines?

• Deciding which countries to prioritize

• Reducing vaccine production costs

• Finding storage space for vaccines

• Predicting which variants will be most prevalent

Which vaccine is the US likely to distribute to other countries due to lack of domestic approval?

• Pfizer

• Moderna

• Johnson & Johnson

• AstraZeneca